177 related articles for article (PubMed ID: 3833119)
1. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):831-6. PubMed ID: 3914253
[TBL] [Abstract][Full Text] [Related]
3. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of cyclophosphamide-induced enhancement of experimental metastasis by splenectomy.
Strzadała L; Rak J; Zioło E; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):399-403. PubMed ID: 2639636
[TBL] [Abstract][Full Text] [Related]
6. The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.
Carmel RJ; Brown JM
Cancer Res; 1977 Jan; 37(1):145-51. PubMed ID: 137074
[TBL] [Abstract][Full Text] [Related]
7. LL2 cell line derived from transplantable murine Lewis lung carcinoma--maintenance in vitro and growth characteristics.
Duś D; Budzyński W; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1985; 33(6):817-23. PubMed ID: 3833118
[TBL] [Abstract][Full Text] [Related]
8. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
Kovnat A; Khoo K; Selby P; Tannock I
Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
[TBL] [Abstract][Full Text] [Related]
9. Stem-cell survival and tumor control in the Lewis lung carcinoma.
Steel GG; Adams K
Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes.
Hill RP; Stanley JA
Cancer Treat Rep; 1977; 61(1):29-36. PubMed ID: 861961
[TBL] [Abstract][Full Text] [Related]
11. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
13. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
Yamamoto T; Yamashita T; Tsubura E
Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of pulmonary metastasis by Nocardia rubra cell wall skeleton, with special reference to macrophage activation.
Kagawa K; Yamashita T; Tsubura E; Yamamura Y
Cancer Res; 1984 Feb; 44(2):665-70. PubMed ID: 6692370
[TBL] [Abstract][Full Text] [Related]
16. Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labeled cell inoculation.
de Ruiter J; Smink T; van Putten LM
Cancer Treat Rep; 1976 Apr; 60(4):465-70. PubMed ID: 1064469
[TBL] [Abstract][Full Text] [Related]
17. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
[TBL] [Abstract][Full Text] [Related]
18. The influence of Fluosol-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma.
Teicher BA; Jacobs JL; Kelley MJ
Invasion Metastasis; 1988; 8(1):45-56. PubMed ID: 3343092
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
Borgström P; Torres Filho IP; Hartley-Asp B
Anticancer Res; 1995; 15(3):719-28. PubMed ID: 7544090
[TBL] [Abstract][Full Text] [Related]
20. Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII).
Khariwala SS; Kjaergaard J; Lorenz R; Van Lente F; Shu S; Strome M
Laryngoscope; 2006 May; 116(5):814-20. PubMed ID: 16652094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
